Patent application number | Description | Published |
20100152822 | SYSTEM AND METHOD FOR DETERMINING AND CONTROLLING CORE BODY TEMPERATURE - Systems and methods for accurate temperature modification of a patient, or selected regions thereof, including inducing hypothermia. The temperature modification is accomplished using an in-dwelling heat exchange catheter within which a fluid heat exchange medium circulates. A heat exchange cassette attached to the circulatory flow lines of the catheter, the heat exchange cassette being sized to engage a cavity within a control unit. A temperature measurement scheme for obtaining body core temperature is provided, including methods of obtaining and analyzing temperature data to provide feedback to the control unit for use in controlling the heating and cooling of the heat exchange medium so as to heat or cool a patient to a desired target temperature. | 06-17-2010 |
20120191166 | SYSTEM AND METHOD FOR DETERMINING AND CONTROLLING CORE BODY TEMPERATUE - Systems and methods for accurate temperature modification of a patient, or selected regions thereof, including inducing hypothermia. The temperature modification is accomplished using an in-dwelling heat exchange catheter within which a fluid heat exchange medium circulates. A heat exchange cassette attached to the circulatory flow lines of the catheter, the heat exchange cassette being sized to engage a cavity within a control unit. A temperature measurement scheme for obtaining body core temperature is provided, including methods of obtaining and analyzing temperature data to provide feedback to the control unit for use in controlling the heating and cooling of the heat exchange medium so as to heat or cool a patient to a desired target temperature. | 07-26-2012 |
20140058484 | SYSTEM AND METHOD FOR DETERMINING AND CONTROLLING CORE BODY TEMPERATURE - Systems and methods for accurate temperature modification of a patient, or selected regions thereof, including inducing hypothermia. The temperature modification is accomplished using an in-dwelling heat exchange catheter within which a fluid heat exchange medium circulates. A heat exchange cassette attached to the circulatory flow lines of the catheter, the heat exchange cassette being sized to engage a cavity within a control unit. A temperature measurement scheme for obtaining body core temperature is provided, including methods of obtaining and analyzing temperature data to provide feedback to the control unit for use in controlling the heating and cooling of the heat exchange medium so as to heat or cool a patient to a desired target temperature. | 02-27-2014 |
Patent application number | Description | Published |
20090037422 | COMBINING CAPTURE AND APPLY IN A DISTRIBUTED INFORMATION SHARING SYSTEM - In accordance with an embodiment of the present invention, an information sharing mechanism comprising a memory structure may be provided in a database system. In an embodiment, mined information transferred by a capture process to an associated apply process can be written into the memory structure without taking any latch. Similarly, the mined information can be read by the apply process from the memory structure without taking any latch. The capture and apply processes may work cooperatively to establish a safe point in log mining under various circumstances such as in an initial startup state, in a steady state, in a process restart scenario in the middle of information sharing. In some embodiments, the information sharing mechanism supports both checkpoint-free and checkpoint modes of log mining by the capture process. In addition, both the capture process and the apply process may employ an eager apply approach to increase processing capacity. | 02-05-2009 |
20100036810 | AUTOMATED TOPOLOGY-BASED STATISTICS MONITORING AND PERFORMANCE ANALYSIS - A computer is programmed to parse a network that interconnects databases in a distributed database system, into a number of paths, wherein each path starts in a source database that is a source of changes and ends in a destination database that uses the changes to replicate the source database. The computer identifies databases that occur within each path in the network, and queries the identified databases to obtain statistics for each path. Statistics along each path are analyzed automatically, to identify a component in each path as a candidate for further investigation. The identified component may be marked as a bottleneck e.g. if there are no other paths connected to it. Alternatively the identified component may be a source of changes for another path that has a bottleneck or that has another candidate for further investigation. The identified bottleneck is displayed to the user with recommendations for improvement. | 02-11-2010 |
20120109889 | Automated Topology-Based Statistics Monitoring And Performance Analysis - A computer is programmed to parse a network that interconnects databases in a distributed database system, into a number of paths, wherein each path starts in a source database that is a source of changes and ends in a destination database that uses the changes to replicate the source database. The computer identifies databases that occur within each path in the network, and queries the identified databases to obtain statistics for each path. Statistics along each path are analyzed automatically, to identify a component in each path as a candidate for further investigation. The identified component may be marked as a bottleneck e.g. if there are no other paths connected to it. Alternatively the identified component may be a source of changes for another path that has a bottleneck or that has another candidate for further investigation. The identified bottleneck is displayed to the user with recommendations for improvement. | 05-03-2012 |
Patent application number | Description | Published |
20090010924 | Apoptotic Anti-IgE Antibodies - The present application relates to apoptotic anti-IgE antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use in the treatment of IgE-mediated disorders. | 01-08-2009 |
20090087428 | ANTI-FC-GAMMA RIIB RECEPTOR ANTIBODY AND USES THEREFOR - The present application describes antibodies that selectively bind human FcγRIIB, with little or no binding to other human FcγRs, e.g., human FcγRIIA. The invention also provides isolated bispecific antibodies comprising an antibody that selectively binds FcγRIIB, and a second antibody that specifically binds an activating receptor. Various uses, including therapeutic uses, for those antibodies are also described, including administration with anti-tumor antibodies and methods of inhibiting immune responses and suppressing histamine release. | 04-02-2009 |
20120144512 | TRANSGENIC ANIMALS EXPRESSING HUMAN IGE-M1' - The present application relates to apoptotic anti-IgE antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use in the treatment of IgE-mediated disorders. | 06-07-2012 |
20120149881 | APOPTOTIC ANTI-IGE ANTIBODIES - The present application relates to apoptotic anti-IgE antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use in the treatment of IgE-mediated disorders. | 06-14-2012 |
20120177635 | METHODS OF USING APOPTOTIC ANTI-IGE ANTIBODIES - The present application relates to apoptotic anti-IgE antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use in the treatment of IgE-mediated disorders. | 07-12-2012 |
20120178127 | Nucleic acid encoding apoptotic anti-ige antibodies - The present application relates to apoptotic anti-IgE antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use in the treatment of IgE-mediated disorders. | 07-12-2012 |
20140115729 | APOPTOTIC ANTI-IGE ANTIBODIES - The present application relates to apoptotic anti-IgE antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use in the treatment of IgE-mediated disorders. | 04-24-2014 |
Patent application number | Description | Published |
20090257978 | Antiviral coumpounds - The invention is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds. | 10-15-2009 |
20110135599 | ANTIVIRAL COMPOUNDS - The present application includes novel inhibitors of HCV, compositions containing such compounds, therapeutic methods that include the administration of such compounds. | 06-09-2011 |
20110135604 | ANTIVIRAL COMPOUNDS - The invention is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds. | 06-09-2011 |
20120190866 | ANTIVIRAL COMPOUNDS - The invention is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds. | 07-26-2012 |
20130053577 | ANTIVIRAL COMPOUNDS - The invention is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds. | 02-28-2013 |
20130274439 | ANTIVIRAL COMPOUNDS - The invention is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds. | 10-17-2013 |
20130338142 | IMIDAZOPYRAZINE SYK INHIBITORS - Certain imidazopyrazines and pharmaceutical compositions thereof are provided herein. Methods of treating patients suffering from certain diseases and disorders responsive to the inhibition of Syk activity, which comprises administering to such patients an amount of an imidazopyrazine compound effective to reduce signs or symptoms of the disease or disorder are provided. | 12-19-2013 |
20150080569 | ANTIVIRAL COMPOUNDS - The invention is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds. | 03-19-2015 |